Nanoform and Celanese Expand Collaboration into Long-Acting Biologics Delivery Through Small Implants
Press release Nanoform Finland Plc September 5, 2024 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform and Celanese Expand Collaboration INTO Long-Acting BIOLOGICS DELIVERY THROUGH SMALL IMPLANTS Helsinki, Finland & Dallas, US – September 5, 2024 - Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, and Celanese Corporation (“Celanese”), a global specialty materials and chemical company, today announced an expansion of their collaboration to cover biologic drug delivery. The companies will combine Nanoform’s Biologics platform